These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 3291768)

  • 21. Targeted drug delivery strategies to treat lung metastasis.
    Bar J; Herbst RS; Onn A
    Expert Opin Drug Deliv; 2009 Oct; 6(10):1003-16. PubMed ID: 19663628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simultaneous delivery of doxorubicin and GG918 (Elacridar) by new polymer-lipid hybrid nanoparticles (PLN) for enhanced treatment of multidrug-resistant breast cancer.
    Wong HL; Bendayan R; Rauth AM; Wu XY
    J Control Release; 2006 Dec; 116(3):275-84. PubMed ID: 17097178
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liposomal drug delivery systems--clinical applications.
    Goyal P; Goyal K; Vijaya Kumar SG; Singh A; Katare OP; Mishra DN
    Acta Pharm; 2005 Mar; 55(1):1-25. PubMed ID: 15907221
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of polyanhydrides as localized drug carriers.
    Jain JP; Modi S; Domb AJ; Kumar N
    J Control Release; 2005 Apr; 103(3):541-63. PubMed ID: 15820403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect.
    Maeda H; Bharate GY; Daruwalla J
    Eur J Pharm Biopharm; 2009 Mar; 71(3):409-19. PubMed ID: 19070661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sterically stabilized anti-G(M3), anti-Le(x) immunoliposomes: targeting to B16BL6, HRT-18 cancer cells.
    Nam SM; Kim HS; Ahn WS; Park YS
    Oncol Res; 1999; 11(1):9-16. PubMed ID: 10451027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Targeting therapy for lung cancer].
    Takahashi H; Gi H; Tamachi Y; Tsuchida T; Taira O; Kato H
    Gan To Kagaku Ryoho; 1994 May; 21(6):749-54. PubMed ID: 8185330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Formulation, preparation and evaluation of flunarizine-loaded lipid microspheres.
    Wang YJ; Wang J; Zhang HY; He HB; Tang X
    J Pharm Pharmacol; 2007 Mar; 59(3):351-7. PubMed ID: 17331337
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparation and biological characterization of polymeric micelle drug carriers with intracellular pH-triggered drug release property: tumor permeability, controlled subcellular drug distribution, and enhanced in vivo antitumor efficacy.
    Bae Y; Nishiyama N; Fukushima S; Koyama H; Yasuhiro M; Kataoka K
    Bioconjug Chem; 2005; 16(1):122-30. PubMed ID: 15656583
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Controlled-release of doxorubicin from poly(lactide-co-glycolide) microspheres significantly enhances cytotoxicity against cultured AIDS-related Kaposi's sarcoma cells.
    Mallery SR; Pei P; Kang J; Ness GM; Ortiz R; Touhalisky JE; Schwendeman SP
    Anticancer Res; 2000; 20(5A):2817-25. PubMed ID: 11062689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Controlled application and scheduled removal of nanoparticle based chemotherapeutics (CARL) will reduce dose limiting adverse events in anticancer chemotherapy.
    Pütz G; Schmah O; Eckes J; Hug MJ; Winkler K
    Med Hypotheses; 2009 Apr; 72(4):393-7. PubMed ID: 19147297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anticancer drug delivery with nanoparticles.
    Conti M; Tazzari V; Baccini C; Pertici G; Serino LP; De Giorgi U
    In Vivo; 2006; 20(6A):697-701. PubMed ID: 17203748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of local tumor growth with paclitaxel-loaded microspheres.
    Azouz SM; Walpole J; Amirifeli S; Taylor KN; Grinstaff MW; Colson YL
    J Thorac Cardiovasc Surg; 2008 May; 135(5):1014-21. PubMed ID: 18455578
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multifunctional nanoparticles for imaging, delivery and targeting in cancer therapy.
    Gindy ME; Prud'homme RK
    Expert Opin Drug Deliv; 2009 Aug; 6(8):865-78. PubMed ID: 19637974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Targeting therapy of cancer, using hormones as carriers].
    Ohsawa N
    Nihon Rinsho; 1989 Jun; 47(6):1417-22. PubMed ID: 2770003
    [No Abstract]   [Full Text] [Related]  

  • 37. [Specificity of anticancer treatment:aims and limits of targeting. I. Targeting carriers].
    Manil L; Couvreur P
    Rev Med Liege; 1986 Dec; 41(24):977-95. PubMed ID: 3544131
    [No Abstract]   [Full Text] [Related]  

  • 38. Perspectives in drug development for cancer therapy in Asia.
    Nakagawa K; Tsurutani J
    Chin Clin Oncol; 2012 Dec; 1(2):17. PubMed ID: 25841395
    [No Abstract]   [Full Text] [Related]  

  • 39. Improvement of intraperitoneal chemotherapy for rat ovarian cancer using cisplatin-containing microspheres.
    Kumagai S; Sugiyama T; Nishida T; Ushijima K; Yakushiji M
    Jpn J Cancer Res; 1996 Apr; 87(4):412-7. PubMed ID: 8641974
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Current problems and future perspectives in drug delivery systems for cancer therapy].
    Mizushima Y; Shoji Y; Saotome T; Yanagawa A; Nakagawa T
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):1077-82. PubMed ID: 3291768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.